Desmoplastic small round cell tumor (DSRCT) is defined by a chimeric
transcription factor, resulting from fusion of the N-terminal domain of the
Ewing's sarcoma gene EWS to the three C-terminal zinc fingers of the
Wilms' tumor suppressor WT1. Although
DNA-binding sites have been defined for the uninterrupted WT1 zinc finger domains, the most prevalent
isoforms of both WT1 and EWS-WT1 have an insertion of three
amino acids [
lysine,
threonine, and
serine (KTS)], which abrogates binding to known consensus sequences and transactivation of known target genes. Here, we used
cDNA subtractive hybridization to identify an endogenous gene, LRRC15, which is specifically up-regulated after inducible expression of EWS-WT1(+KTS) in
cancer cell lines, and is expressed within primary DSRCT cells. The chimeric
protein binds in vitro and in vivo to a specific
element upstream of LRRC15, leading to dramatic transcriptional activation. Mutagenesis studies define the optimal binding site of the (+KTS)
isoform of EWS-WT1 as 5'-GGAGG(A/G)-3'. LRRC15 encodes a
leucine-rich transmembrane
protein, present at the leading edge of migrating cells, the expression of which in normal tissues is restricted to the invasive cytotrophoblast layer of the placenta; small interfering (
siRNA)-mediated suppression of LRRC15 expression in
breast cancer cells leads to abrogation of invasiveness in vitro. Together, these observations define the consequence of (KTS) insertion within WT1-derived zinc fingers, and identify a novel EWS-WT1 transcriptional target implicated in
tumor invasiveness.